Cargando…

Nutritional and clinical outcomes of chemoradiotherapy for clinical T1N0M0 esophageal carcinoma

Purpose: Whether nutritional assessment and management improves clinical outcomes in patients with clinical T1N0M0 esophageal squamous cell carcinoma (ESCC) who undergo chemoradiotherapy remains to be demonstrated. This study aimed to determine the nutritional status of such patients pre- and post-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakanaka, Katsuyuki, Fujii, Kota, Ishida, Yuichi, Miyamoto, Shin’ichi, Horimatsu, Takahiro, Muto, Manabu, Mizowaki, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497910/ https://www.ncbi.nlm.nih.gov/pubmed/31118785 http://dx.doi.org/10.2147/CMAR.S189518

Ejemplares similares

Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2018)

Association of Chemoradiotherapy With Thoracic Vertebral Fractures in Patients With Esophageal Cancer
por: Fujii, Kota, et al.
Publicado: (2020)

Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2017)

Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma without hypopharyngeal invasion: dose distribution and clinical outcome
por: Ishida, Yuichi, et al.
Publicado: (2019)

Therapy-Related Acute Myeloid Leukemia 2 Months after Chemoradiotherapy for Esophageal Cancer: A Case Report
por: Hiraoka, Shinya, et al.
Publicado: (2020)

Association of volumetric-modulated arc therapy with radiation pneumonitis in thoracic esophageal cancer
por: Inoo, Hiroyuki, et al.
Publicado: (2022)

A Case Report of Locally Advanced Anal Cancer with Solitary Cutaneous Nodular Metastasis in the Ipsilateral Labia Majora Treated with Definitive Chemoradiotherapy
por: Sakanaka, Katsuyuki, et al.
Publicado: (2019)

Adaptive radiotherapy in locally advanced esophageal cancer with atelectasis: a case report
por: Sakanaka, Katsuyuki, et al.
Publicado: (2020)

Preoperative chemoradiotherapy for locally advanced low rectal cancer using intensity-modulated radiotherapy to spare the intestines: a single-institutional pilot trial
por: Sakanaka, Katsuyuki, et al.
Publicado: (2021)

Effect of long fasting on myocardial accumulation in (18)F-fluorodeoxyglucose positron emission tomography after chemoradiotherapy for esophageal carcinoma
por: Ishida, Yuichi, et al.
Publicado: (2018)

Long-term complications of definitive chemoradiotherapy for esophageal cancer using the classical method
por: Ito, Hitoshi, et al.
Publicado: (2017)

Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution
por: Ogura, Kengo, et al.
Publicado: (2013)

Preclinical Validation of Talaporfin Sodium-Mediated Photodynamic Therapy for Esophageal Squamous Cell Carcinoma
por: Ohashi, Shinya, et al.
Publicado: (2014)

Tissue Damage in the Canine Normal Esophagus by Photoactivation with Talaporfin Sodium (Laserphyrin): A Preclinical Study
por: Horimatsu, Takahiro, et al.
Publicado: (2012)

Readministration of Nivolumab after Persistent Immune-related Colitis in a Patient with Recurrent Melanoma
por: Fujii, Yosuke, et al.
Publicado: (2017)

Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control
por: Ogura, Kengo, et al.
Publicado: (2013)

Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma
por: Deng, Wei, et al.
Publicado: (2020)

Reducing variability among treatment machines using knowledge‐based planning for head and neck, pancreatic, and rectal cancer
por: Hirashima, Hideaki, et al.
Publicado: (2021)

Management of Clinical T1N0M0 Esophageal Cancer
por: Yang, Andrew J., et al.
Publicado: (2019)

A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer
por: Yano, Tomonori, et al.
Publicado: (2016)

Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma
por: Suwa, Tatsuya, et al.
Publicado: (2021)

A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508
por: Kurokawa, Yukinori, et al.
Publicado: (2009)

Repeated talaporfin sodium photodynamic therapy for esophageal cancer: safety and efficacy
por: Tamaoki, Masashi, et al.
Publicado: (2021)

Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa
por: Uchinami, Yusuke, et al.
Publicado: (2016)

Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer
por: Saitoh, Jun-ichi, et al.
Publicado: (2017)

Nonsurgical Management Following Local Resection for Early Rectal Cancer in Patients with High-risk Factors: A Single-institute Experience
por: Nishizaki, Daisuke, et al.
Publicado: (2020)

Preoperative chemoradiotherapy followed by local excision in clinical T2N0 rectal cancer
por: Shin, Young Seob, et al.
Publicado: (2016)

Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer
por: Ueda, Hiroto, et al.
Publicado: (2017)

An Interdisciplinary Nutrition Support Team Improves Clinical and Hospitalized Outcomes of Esophageal Cancer Patients with Concurrent Chemoradiotherapy
por: Cong, Ming-Hua, et al.
Publicado: (2015)

Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy
por: Bang, Hyun Jin, et al.
Publicado: (2023)

The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma
por: Song, Tao, et al.
Publicado: (2020)

Induction therapy for clinical stage T2N0M0 esophageal cancer: A systematic review and meta-analysis
por: Lv, Hong-Wei, et al.
Publicado: (2018)

Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors
por: Narabayashi, Masaru, et al.
Publicado: (2012)

Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study
por: Miyazaki, Tomohiko, et al.
Publicado: (2022)

Influence of adverse effects of neoadjuvant chemoradiotherapy on the prognosis of patients with early-stage esophageal cancer (cT1b-cT2N0M0) based on the SEER database
por: Cao, Xiying, et al.
Publicado: (2023)

Induction Chemoradiotherapy Followed by Surgical Resection for Clinical T3 or T4 Locally Advanced Non–Small Cell Lung Cancer
por: Shien, Kazuhiko, et al.
Publicado: (2012)

Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer
por: Goto, Yoko, et al.
Publicado: (2018)

Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
por: Jain, Rishi, et al.
Publicado: (2020)

Role of surgery in T4N0-3M0 esophageal cancer
por: Qi, Chen, et al.
Publicado: (2023)

Clinical Characteristics of Patients With Ineffective Esophageal Motility by Chicago Classification Version 4.0 Compared to Chicago Classification Version 3.0
por: Kurin, Michael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e4a2rnmnhdjugv5abm86m5dkr3